Sertraline (Drug class: Selective serotonin reuptake inhibitors (SSRIs))
Oral sertraline; US tablet-label indications. Pediatric approval is for OCD at ages 6–17, not every adult indication. Formulation-specific instructions are outside this guide.
Educational draft · independent clinical review pending. Silent mechanism animation available; no recorded narration.
Uses / Symptoms
- Major depression and obsessive-compulsive disorder (OCD)
- Panic disorder, PTSD and social anxiety disorder
- Premenstrual dysphoric disorder (PMDD)
Effects
- Can reduce symptoms of the diagnosed condition
- Changes serotonin signaling in the brain
- Full benefit may take weeks or longer
Side effects
- Nausea, diarrhea, sweating or tremor
- Reduced sex drive or other sexual difficulties
- Important risks include suicidal thoughts and behaviors in younger people, serotonin syndrome and bleeding
How does Sertraline work? What is the Mechanism Of Action (MOA)?
Sertraline slows the recycling of serotonin, a chemical that nerve cells use to communicate. This changes serotonin signaling and can help symptoms, but full benefit may take weeks or longer.
The mechanism, step by step
- Serotonin carries a message
Nerve cells release serotonin as a chemical signal.
- SERT normally recycles serotonin
The serotonin transporter moves serotonin back into the releasing cell.
- Sertraline inhibits that transporter
Less serotonin is taken back up, changing serotonin signaling.
- Symptoms may improve over time
Clinical benefit can take weeks or longer; transporter inhibition is not the whole explanation of recovery.
Questions & Answers (FAQ)
How does Sertraline work?
Sertraline slows the recycling of serotonin, a chemical that nerve cells use to communicate. This changes serotonin signaling and can help symptoms, but full benefit may take weeks or longer.
What is sertraline used for?
US tablet labeling covers major depressive disorder, OCD, panic disorder, PTSD, social anxiety disorder and PMDD. For children and adolescents, established labeled use is OCD at ages 6–17; do not assume all adult indications apply.
Why might I not feel better immediately?
Full benefit may take weeks or longer. The early effect on serotonin transport and the timing of symptom improvement are not the same thing; discuss progress and side effects with the prescriber.
What side effects are common?
Nausea, loose stools, sweating, tremor and appetite changes can occur. Reduced sex drive and other sexual difficulties are also important to discuss rather than silently tolerate.
What is the boxed warning?
Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Monitor for worsening mood or unusual behavior, especially early in treatment or after changes; seek urgent help for immediate danger.
What is serotonin syndrome?
It is a potentially life-threatening reaction that can include agitation or confusion, fever, sweating, tremor and muscle stiffness. Risk rises with other serotonergic medicines; suspected symptoms need urgent medical assessment.
Which combinations need special attention?
MAO inhibitors and pimozide are contraindicated combinations. Other serotonergic products can raise serotonin-syndrome risk, while NSAIDs such as ibuprofen, antiplatelets and anticoagulants can add to bleeding risk; have a pharmacist review the full medicine list.
Can sertraline be stopped suddenly?
Abrupt stopping can cause withdrawal symptoms such as dizziness, nausea, anxiety and sleep disturbance. Discuss a supervised stopping plan with the prescriber rather than changing treatment on your own.
Why does the prescriber ask about bipolar disorder?
Antidepressant treatment can trigger mania or hypomania in susceptible people. Personal and family histories of bipolar disorder, mania or hypomania matter when assessing treatment.
Do these explanations replace medical advice?
No. They summarize selected label and research information, not every risk or an individual treatment plan. Formulation, other medicines, pregnancy and medical history can change the discussion.
Online stores and Pharmacies (Buy)
Sertraline requires a prescription. This guide does not compare pharmacy prices or stock; use a licensed pharmacy and check the exact prescribed formulation.
No live price, stock or individual eligibility is verified here.
Animation chapters, evidence & visual limits
US oral sertraline, with adult mood and anxiety indications as context. No pediatric-indication extension or dose instructions. Educational draft; independent clinical review pending.
Transporter and messenger shapes are symbols. No chemical-imbalance diagnosis, individualized serotonin level, guaranteed time to response or molecular binding pose is depicted.
Original conceptual illustrations. AI-assisted editorial source check; independent clinical review pending. No recorded narration.
Chapter 1: Serotonin carries a message
Neurons release serotonin to communicate. A transporter helps control how long serotonin remains outside the cell.
Separate the messenger, its receptors and its transporter from the outset. The animation concerns one communication system; it should not identify depression with a measurable serotonin deficiency.
One simplified synapse represents signaling, not a diagnostic model of depression.
- Sertraline hydrochloride tablets US prescribing information · Sections 1, 5, 6, 12.1–12.2 and 14; DailyMed update 2024-02-09; mechanism text rechecked directly · US product label · checked 2026-10-17
- Coleman and Gouaux (2018): Structural recognition of antidepressants by human SERT · Abstract; engineered thermostable human SERT structures with sertraline; DOI 10.1038/s41594-018-0026-8 · Primary structural study · checked 2026-10-17
Chapter 2: SERT recycles serotonin
SERT moves serotonin back into the releasing neuron, helping clear it from the space between cells.
SERT-mediated uptake is a transport process, not neurotransmitter destruction and not the action of a serotonin receptor. Structural studies identify a central substrate site within the transporter.
Reuptake is one clearance process; not all serotonin follows this path.
- Coleman and Gouaux (2018): Structural recognition of antidepressants by human SERT · Abstract; engineered thermostable human SERT structures with sertraline; DOI 10.1038/s41594-018-0026-8 · Primary structural study · checked 2026-10-17
- Sertraline hydrochloride tablets US prescribing information · Sections 1, 5, 6, 12.1–12.2 and 14; DailyMed update 2024-02-09; mechanism text rechecked directly · US product label · checked 2026-10-17
Chapter 3: Sertraline slows reuptake
Sertraline inhibits SERT, leaving more serotonin available outside neurons to influence signaling.
Engineered human SERT structures place sertraline in the central substrate site and show an outward-open inhibited conformation. This supports inhibition of transport; the animation deliberately does not reconstruct atomic contacts.
Schematic availability change, not a measured concentration or occupancy value.
- Coleman and Gouaux (2018): Structural recognition of antidepressants by human SERT · Abstract; engineered thermostable human SERT structures with sertraline; DOI 10.1038/s41594-018-0026-8 · Primary structural study · checked 2026-10-17
- Sertraline hydrochloride tablets US prescribing information · Sections 1, 5, 6, 12.1–12.2 and 14; DailyMed update 2024-02-09; mechanism text rechecked directly · US product label · checked 2026-10-17
Chapter 4: Signaling changes over time
SERT engagement and symptom improvement are different measures. Full benefit may take weeks or longer.
Human PET studies including sertraline show transporter engagement after treatment. PET does not directly measure happiness, all synaptic serotonin, or the complete network adaptations involved in recovery.
Clinical timing varies; a scan or transporter-occupancy estimate cannot predict an individual's outcome.
- Meyer et al. (2004): PET serotonin-transporter occupancy study · Abstract; 77 subjects across five medications; before/after four-week PET measurements · Primary human target-engagement study · checked 2026-10-17
- MedlinePlus: Sertraline · How should this medicine be used; side effects; revised 2025-10-15 · Official patient medication information · checked 2026-10-17
Chapter 5: Symptoms need their own assessment
Clinical benefit is assessed through changes in symptoms and daily function, not by counting serotonin molecules.
Sertraline's clinical evidence spans defined psychiatric conditions. The animation's molecular model cannot establish a new indication, relative superiority or an individual treatment decision.
A mechanism diagram is not an individual response forecast or proof of a serotonin-deficiency cause.
- Sertraline hydrochloride tablets US prescribing information · Sections 1, 5, 6, 12.1–12.2 and 14; DailyMed update 2024-02-09; mechanism text rechecked directly · US product label · checked 2026-10-17
- Meyer et al. (2004): PET serotonin-transporter occupancy study · Abstract; 77 subjects across five medications; before/after four-week PET measurements · Primary human target-engagement study · checked 2026-10-17
Chapter 6: Effects extend beyond mood
Benefits and unwanted effects need separate attention, including gastrointestinal symptoms, sexual effects and important interaction risks.
The label documents platelet serotonin-uptake inhibition as well as CNS action. Bleeding, serotonin syndrome and clinical worsening are safety concerns, not evidence of effective treatment.
Selected safety context only; this does not replace the full Medication Guide.
- Sertraline hydrochloride tablets US prescribing information · Sections 1, 5, 6, 12.1–12.2 and 14; DailyMed update 2024-02-09; mechanism text rechecked directly · US product label · checked 2026-10-17
- MedlinePlus: Sertraline · How should this medicine be used; side effects; revised 2025-10-15 · Official patient medication information · checked 2026-10-17
References & Sources
Source pages checked October 16, 2026. AI-assisted editorial source checking is not independent clinical review. Sources support the summary, mechanism, safety and access information; references are also kept beside each question.
- DailyMed: sertraline hydrochloride tablets — US prescribing information ↗ · 1; 4–7; 8.4; 12.1–12.3; Medication Guide. DailyMed updated February 9, 2024; checked October 16, 2026.
- MedlinePlus: sertraline ↗ · Uses, precautions, delayed benefit, stopping treatment; checked October 16, 2026.
- Coleman and Gouaux (2018): human serotonin transporter bound to antidepressants ↗ · Primary X-ray study of engineered human SERT variants, including sertraline; checked October 16, 2026.
Selective US-label-based information, not a complete safety list or a personal treatment recommendation. Do not change treatment based on this page; use the product-specific label and your care team's advice.